Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting

NCT03912883 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT03912883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03912883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Active, not recruiting
Start date
October 12, 1999
Completion date
January 1, 2030
Enrollment
3,350 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer